DENTI.AI PIONEERS FDA-CLEARED PATHOLOGY DETECTION IN BOTH PANORAMIC AND INTRAORAL X-RAYS WITH LAUNCH OF DENTI.AI DETECT
TORONTO, Oct. 25, 2023 /PRNewswire/ -- Denti.AI, a pioneer in leveraging Artificial Intelligence for dental pathology detection, odontogram and periodontal charting automation, proudly announces the 510(k) clearance by the FDA of its innovative product, Denti.AI Detect. This state-of-the-art imaging solution is engineered to aid dental professionals in identifying prevalent dental diseases such as caries, periapical lesions, and bone loss from dental x-rays. Clinical studies reveal a notable enhancement in disease detection by all the two dozen participating dentists, unlocking 26% extra treatment opportunities with Denti.AI Detect.
- TORONTO, Oct. 25, 2023 /PRNewswire/ -- Denti.AI, a pioneer in leveraging Artificial Intelligence for dental pathology detection, odontogram and periodontal charting automation, proudly announces the 510(k) clearance by the FDA of its innovative product, Denti.AI Detect.
- Clinical studies reveal a notable enhancement in disease detection by all the two dozen participating dentists, unlocking 26% extra treatment opportunities with Denti.AI Detect.
- A key distinguishing feature of Denti.AI Detect is its industry-first FDA clearance for disease detection on panoramic images.
- As part of its launch celebration, Denti.AI is offering special pricing terms for Denti.AI Detect & Auto-Chart until the end of the year.